AMY MCDONNELL: Open Payments
NPI 1770582702 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,373 in 112 payments from 19 companies in 2025. Trend: 2023 $1,284 · 2024 $1,691 · 2025 $2,373
Food & beverage: $2,373
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $677 |
| Janssen Biotech, Inc. | 29 | $521 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $229 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $139 |
| GENZYME CORPORATION | 5 | $135 |
| QOL Medical, LLC | 3 | $90 |
| Medtronic, Inc. | 2 | $82 |
| Ipsen Biopharmaceuticals, Inc | 3 | $77 |
| Ardelyx, Inc. | 4 | $67 |
| Phathom Pharmaceuticals, Inc. | 4 | $66 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ENTYVIO, LINZESS, XIFAXAN, DUPIXENT, Sucraid.
Industry payments across VA — which companies pay providers there.
